Could a simple drug cocktail stop Post-Birth bleeding?
NCT ID NCT07318467
First seen Jan 09, 2026 · Last updated Jun 22, 2026 · Updated 28 times
Summary
This study tests whether giving a combination of three drugs (oxytocin, tranexamic acid, and an ergot derivative) right after a C-section can prevent postpartum hemorrhage better than the standard single drug, carbetocin. The trial will enroll 80 women undergoing planned or unplanned C-sections. Researchers will measure blood loss and compare the two approaches.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST PARTUM HEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
a combination of intravenous oxytocin, intravenous tranexamic acid, and intramuscular ergot derivative
What this could lead to
If it works, this could offer a more effective and cheaper way to prevent dangerous bleeding after C-sections.
What could go wrong
This is a small, early-stage trial with only 80 participants, so results may not apply to all women. The combination also carries a higher risk of side effects like nausea or high blood pressure.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.